Trial Profile
A Single Dose Study to Investigate the Pharmacokinetics of an Oral Microdose of JNJ-42396302, JNJ-53773187 and JNJ-42692507 in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Apr 2014
Price :
$35
*
At a glance
- Drugs JNJ 42396302 (Primary) ; JNJ 42692507 (Primary) ; JNJ 53773187 (Primary)
- Indications Psychiatric disorders
- Focus Pharmacokinetics
- Sponsors Janssen-Cilag
- 04 Apr 2014 New trial record